Fibrosis pulmonar idiopática (FPI)

 

Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial

Jenkins RG et al.

 

Acceder

Changes in biomarkers with nintedanib and sildenafil in subjects with IPF in the INSTAGE trial: subgroup analysis by right heart dysfunction (RHD)

White ES et al.
 

Acceder

Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial

White ES et al.
 

Acceder

 

 

Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF

Oldham J et al.
 

Acceder

Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry

Liu Y et al.
 

Acceder

Effects of nintedanib in patients with IPF: subgroup analysis by Charlson Comorbidity Index (CCI)

Bendstrup E et al.
 

Acceder

 

 

Monocyte count and decline in forced vital capacity (FVC) in patients with IPF

Tzouvelekis A et al.

 

Acceder

Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study

Poletti V et al.
 

Acceder